These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17470330)
1. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials. Hiestand B; Abraham WT Curr Cardiol Rep; 2007 May; 9(3):182-6. PubMed ID: 17470330 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of nesiritide in patients with acute decompensated heart failure. DeWald TA; Hernandez AF Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602 [TBL] [Abstract][Full Text] [Related]
3. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure. Dandamudi S; Chen HH Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831 [TBL] [Abstract][Full Text] [Related]
4. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
5. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure. Yancy CW Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969 [TBL] [Abstract][Full Text] [Related]
6. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide. Noviasky JA Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696 [TBL] [Abstract][Full Text] [Related]
7. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Munger MA; Ng TM; Van Tassell BW Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695 [TBL] [Abstract][Full Text] [Related]
8. Impact of nesiritide on renal function and mortality in patients suffering from heart failure. Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976 [TBL] [Abstract][Full Text] [Related]
9. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure. Ma X; Sun F; Ma J Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132 [No Abstract] [Full Text] [Related]
10. Nesiritide for acute decompensated heart failure: does the benefit justify the risk? Sackner-Bernstein J; Aaronson KD Curr Cardiol Rep; 2007 May; 9(3):187-93. PubMed ID: 17470331 [TBL] [Abstract][Full Text] [Related]
11. [Nesiritide in heart failure: commercial success or therapeutic advance?]. Stampfli T; Perrier A Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047 [TBL] [Abstract][Full Text] [Related]
12. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Emerman CL Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428 [TBL] [Abstract][Full Text] [Related]
14. Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure. Colbert K; Greene MH Crit Care Nurs Q; 2003; 26(1):40-4. PubMed ID: 12669946 [TBL] [Abstract][Full Text] [Related]